SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opko Health, Inc. – ‘10-K’ for 12/31/11 – ‘EX-21’

On:  Thursday, 3/15/12, at 4:24pm ET   ·   For:  12/31/11   ·   Accession #:  1193125-12-117417   ·   File #:  1-33528

Previous ‘10-K’:  ‘10-K/A’ on 7/28/11 for 12/31/10   ·   Next:  ‘10-K’ on 3/18/13 for 12/31/12   ·   Latest:  ‘10-K’ on 3/1/24 for 12/31/23   ·   1 Reference:  By:  Opko Health, Inc. – ‘10-K’ on 2/18/21 for 12/31/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/15/12  Opko Health, Inc.                 10-K       12/31/11   45:5.5M                                   Donnelley … Solutions/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.15M 
 2: EX-2.6      Plan of Acquisition, Reorganization, Arrangement,   HTML    210K 
                Liquidation or Succession                                        
 3: EX-21       Subsidiaries List                                   HTML     14K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     15K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     15K 
28: R1          Document and Entity Information                     HTML     43K 
21: R2          Consolidated Balance Sheets                         HTML    130K 
26: R3          Consolidated Balance Sheets (Parenthetical)         HTML     61K 
30: R4          Consolidated Statements of Operations               HTML    123K 
41: R5          Consolidated Statements of Shareholders' Equity     HTML    165K 
22: R6          Consolidated Statements of Stockholders' Equity     HTML     35K 
                (Parenthetical)                                                  
25: R7          Consolidated Statements of Cash Flows               HTML    184K 
20: R8          Business and Organization                           HTML     26K 
16: R9          Summary of Significant Accounting Policies          HTML     46K 
42: R10         Acquisitions, Investments, and Licenses             HTML     93K 
32: R11         Discontinued Operations                             HTML     41K 
31: R12         Composition of Certain Financial Statement          HTML    111K 
                Captions                                                         
36: R13         Debt                                                HTML     39K 
37: R14         Equity Offerings                                    HTML     35K 
35: R15         Shareholders' Equity                                HTML     46K 
38: R16         Equity-Based Compensation                           HTML     55K 
27: R17         Income Taxes                                        HTML     87K 
29: R18         Supplemental Cash Flow Information                  HTML     35K 
34: R19         Related Party Transactions                          HTML     43K 
45: R20         Employee Benefit Plans                              HTML     25K 
39: R21         Commitments and Contingencies                       HTML     22K 
23: R22         Strategic Alliances                                 HTML     17K 
33: R23         Leases                                              HTML     26K 
24: R24         Segments                                            HTML     60K 
15: R25         Fair Value Measurement                              HTML     48K 
40: R26         Derivative Contracts                                HTML     40K 
43: R27         Selected Quarterly Financial Data (Unaudited)       HTML     58K 
19: R28         Subsequent Events                                   HTML     18K 
44: XML         IDEA XML File -- Filing Summary                      XML     55K 
18: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    741K 
 9: EX-101.INS  XBRL Instance -- opk-20111231                        XML    956K 
11: EX-101.CAL  XBRL Calculations -- opk-20111231_cal                XML    140K 
12: EX-101.DEF  XBRL Definitions -- opk-20111231_def                 XML    178K 
13: EX-101.LAB  XBRL Labels -- opk-20111231_lab                      XML    543K 
14: EX-101.PRE  XBRL Presentations -- opk-20111231_pre               XML    338K 
10: EX-101.SCH  XBRL Schema -- opk-20111231                          XSD     69K 
17: ZIP         XBRL Zipped Folder -- 0001193125-12-117417-xbrl      Zip     93K 


‘EX-21’   —   Subsidiaries List


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-21  

Exhibit 21

SUBSIDIARIES OF OPKO HEALTH, INC.

 

NAME

 

JURISDICTION OF INCORPORATION

 

OPKO Instrumentation, LLC

  Delaware

OPKO Pharmaceuticals, LLC

  Delaware

Froptix LLC

  Florida

Claros Diagnostics, LLC

  Delaware

Vidus Ocular, Inc.

  Delaware

Pharma Genexx, S.A.

  Chile

Pharmacos Exakta S.A. de C.V.

  Mexico

FineTech Pharmaceutical Ltd.

  Israel

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/18/21  Opko Health, Inc.                 10-K       12/31/20  111:16M
Top
Filing Submission 0001193125-12-117417   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 5:03:56.1pm ET